CD30 is a target universally expressed in virtually all classical Hodgkin lymphomas (cHL), anaplastic large cell lymphomas (ALCL), and in a proportion of other lymphoma types (8). This evidence concerns the gene TNFRSF8 and anaplastic large cell lymphoma.